Long term motor complications of levodopa: clinical features, mechanisms, and management strategies.
about
Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic SystemLevodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected FindingDopamine depletion alters phosphorylation of striatal proteins in a model of ParkinsonismThe Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.Treatment of dysautonomia in extrapyramidal disordersSolid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride.Neuroprotective Effect of the Marine-Derived Compound 11-Dehydrosinulariolide through DJ-1-Related Pathway in In Vitro and In Vivo Models of Parkinson's Disease.Clinical effectiveness of acupuncture on Parkinson disease: A PRISMA-compliant systematic review and meta-analysis.Diet with LPP for renal patients increases daily energy expenditure and improves motor function in parkinsonian patients with motor fluctuationsTrends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersComparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-enDopamine D2R Agonist-Induced Cardiovascular Effects in Healthy Male Subjects: Potential Implications in Clinical Settings.Levodopa delivery systems: advancements in delivery of the gold standard.Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.Pedunculopontine stimulation from primate to patient.Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: study protocol for a randomized controlled trial.Deep brain stimulation for Parkinson's disease: current status and future outlook.Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent regionally selective, bimodal effects on striatal dopamine kinetics in vivo.Association Between Catechol-O-Methyltransferase (COMT) Gene Polymorphisms, Parkinson's Disease, and Levodopa Efficacy.Surgical insights into Parkinson's disease.Modified Pfeffer Questionnaire for Functional Assessment in Parkinson Disease.Duration of step initiation predicts freezing in Parkinson's disease.Deep brain stimulation for Parkinson's disease prior to L-dopa treatment: A case report.
P2860
Q26738336-B6430A70-DA77-410A-A1BD-DC6E332D377CQ26752867-88006B85-300C-4FF4-887B-6937B05B4E50Q28579756-7F3545DF-8934-4AEB-8F0D-CFE517B466B1Q33872721-E54314F9-05A9-44B0-86F6-3C7091D08DD4Q34409285-797954A0-D4F1-41E6-A1CA-BB1C9D95EBF3Q35794829-717B5514-D250-41BF-BE1B-3E1F6B19ECC1Q36168877-696E36BE-B5DF-43F1-AE77-370A4A11CF87Q36252502-CCEB2598-C98F-409A-BF4F-A0A732303595Q36699948-04FBFF31-2DF3-4F98-A9D9-E4AA6A0F358BQ37249765-792565CE-EC59-47BF-868E-94DBF99FF75FQ37275476-02DA5790-FF2F-4951-B49C-AD2DF57F898BQ37576818-8506A518-5CC1-4FBD-9282-E40E7275B6DEQ37679951-3E24AAD0-B739-4ECD-9009-FC26BF56BD1CQ37737068-37476B57-32D2-4317-B4CA-84F04AC744B7Q37859316-2B043152-F801-4EAD-9951-0463502450EAQ38260834-2A502719-60B1-4052-B77B-BCEEF3F13C78Q38409402-AAFB6F6E-B7AB-483D-A60F-510226A39201Q38842519-71F1D13C-2762-43F3-B00C-BCB09FA0A322Q42754446-0B5EEB8B-989C-4BA4-96A6-5033243779DBQ43662733-14D85779-9E0C-499A-9D6C-F921435E36BBQ51211712-7229BD05-7768-45AC-B286-DE83AA6179E8Q51819238-966E9D1E-52DB-4A71-8F3A-AB084F7116D9Q53617089-0A56ED1E-8F99-4517-91DA-0285C6D075E2Q54868733-5E46E942-97F0-42A4-8006-C5140AC8ECF3
P2860
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Long term motor complications ...... ms, and management strategies.
@ast
Long term motor complications ...... ms, and management strategies.
@en
type
label
Long term motor complications ...... ms, and management strategies.
@ast
Long term motor complications ...... ms, and management strategies.
@en
prefLabel
Long term motor complications ...... ms, and management strategies.
@ast
Long term motor complications ...... ms, and management strategies.
@en
P2860
P356
P1476
Long term motor complications ...... ms, and management strategies.
@en
P2860
P304
P356
10.1136/PGMJ.2003.013912
P407
P577
2004-08-01T00:00:00Z